MALAT1 and acute pancreatitis: <h4>Background/aims</h4>This current research targeted to assess whether long non-coding RNAs MALAT1 and H19, which are accepted to act a pivotal role in the progression of acute pancreatitis (AP), can be used as candidate biomarkers in addressing the diagnosis and severity of AP.<h4>Materials and methods</h4>Healthy volunteers who applied to the Internal Medicine outpatient clinic between October 2022 and June 2023 and patients who were hospitalized and treated for AP in the same period were enrolled in the research.